Press Releases

NEW YORK, March 12, 2020 /PRNewswire/ -- American Skin Association (ASA) has announced the awarding of two coveted research grants under the ASA Milstein Research Scholar Awards program. Douglas Osborne, PhD of University of Colorado Anschutz Medical Campus received the ASA Milstein

CAMBRIDGE, Mass., March 12, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living m

CHICAGO, March 12, 2020 /PRNewswire/ -- SAI Global, the company behind the world leading SAI360 Risk & Business Continuity Management platform, is hosting the first online conference focused solely on business continuity planning and crisis management in the age of COVID-19. The conference will take place virtually March 16 and 17, 2020

ORANGE COUNTY, Calif., March 12, 2020 /PRNewswire/ -- MediPines Corporation, in keeping with their mission of advancing respiratory medicine, has released a statement of guidance

GREENSBORO, N.C., March 12, 2020 /PRNewswire/ -- Mark Gordon has been hired as president of Alamance Regional Medical Center in Burlington. Gordon will also be a senior vice president with Cone Health. He will lead Alamance Regional with a focus on patient, employee and physician satisfaction. 

SEATTLE, March 12, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the fourth quarter and full year ended December 31, 2019."In the latter half of 2019 and beginning of 2020, we further advanced our pacritinib development program, including presenting data at the American Society

PLYMOUTH MEETING, Pa., March 12, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases, today reported financial results for the fourth quarter and year ended

IRVINE, Calif., March 12, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter 2019 financial and operating results on Thursday, March 19, 2020 after the close of the U.S. financial markets and will host a conference call and webcast that day at

HOUSTON, March 12, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced business highlights and financial results for the three months ended

HOUSTON, March 12, 2020 /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-g